Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1

Conditions

Breast Neoplasms 9Neoplasms, Hormone-Dependent 3Carcinoma, Lobular 3Carcinoma, Ductal, Breast 3Prostatic Neoplasms 2Fractures, Bone 2Prostatic Intraepithelial Neoplasia 1Precancerous Conditions 1Osteoporosis 1Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Selenium 4Epoetin Alfa 3Vitamin E 2Darbepoetin alfa 2Aminolevulinic Acid 2tirbanibulin 1human papillomavirus vaccine, L1 type 16, 18 1ferrous sulfate 1ferric gluconate 1alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Toremifene 1Sulindac 1Sucrose 1Soybean Proteins 1Rosuvastatin Calcium 1Radiotherapy, Intensity-Modulated 1Polymerase Chain Reaction 1Ondansetron 1Morphine 1Light Coagulation 1Imiquimod 1Hypericum extract LI 160 1Fenretinide 1Esomeprazole 1Eflornithine 1Early Intervention, Educational 1Dextromethorphan 1Deoxyribonuclease (Pyrimidine Dimer) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precancerous Conditions × Toremifene × Clear all
NCT00106691 2023-06-12

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

GTx

Phase 3 Completed
1,589 enrolled 16 charts
GenitourinaryOther neoplasm

Neoplasms, Precancerous Conditions, Prostatic Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡